nach oben

Erschienen in:

01.08.2018 | News item

US FDA takes key actions for bulk drugs used for compounding

Einloggen, um Zugang zu erhalten

Excerpt

New key actions on bulk drug substances related to compounding of human drug products are being taken to protect patients, says the US FDA. …

including alpha lipoic acid, coenzyme Q10, creatinine monohydrate, pyridoxal 5 phosphate, choline chloride and quercetin dihydrate.

US Food and Drug Administration. FDA continues taking key actions on bulk drug substances used for compounding to advance the regulatory framework governing compounded drugs and to protect patients. Internet Document : 23 Jul 2018. Available from: URL: https://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm614281.htm

Titel: US FDA takes key actions for bulk drugs used for compounding
Publikationsdatum: 01.08.2018
Verlag: Springer International Publishing
Erschienen in: Reactions Weekly / Ausgabe 1/2018
Print ISSN: 0114-9954
Elektronische ISSN: 1179-2051
DOI: https://doi.org/10.1007/s40278-018-49838-9